The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells.
While Mesd was discovered as a specialized molecular endoplasmic reticulum chaperone for the Wnt co-receptors LRP5 and LRP6, recombinant Mesd protein is able to bind to mature LRP5 and LRP6 on the cell surface and acts as a universal antagonist of LRP5/6 modulators. In our previous study, we found t...
Main Authors: | Cuihong Lin, Wenyan Lu, Wei Zhang, Angelina I Londoño-Joshi, Donald J Buchsbaum, Guojun Bu, Yonghe Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3585277?pdf=render |
Similar Items
-
Lethal osteogenesis imperfecta type XX caused by compound heterozygous frameshift mutations in MESD
by: Julian Stürznickel, et al.
Published: (2021-04-01) -
Biallelic variants in MESD, which encodes a WNT-signaling-related protein, in four new families with recessively inherited osteogenesis imperfecta
by: Thao T. Tran, et al.
Published: (2021-10-01) -
Development of a conditional Mesd (mesoderm development) allele for functional analysis of the low-density lipoprotein receptor-related family in defined tissues.
by: Andrew V Taibi, et al.
Published: (2013-01-01) -
Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
by: Wenyan Lu, et al.
Published: (2011-01-01) -
A C-terminally truncated form of β-catenin acts as a novel regulator of Wnt/β-catenin signaling in planarians.
by: Hanxia Su, et al.
Published: (2017-10-01)